News

Dharti Proteins Limited, formerly known as Devika Proteins Limited, has submitted a certificate to the BSE Limited under Regulation 74(5) of the SEBI (Depository and Participants) Regulations, 2018, for the quarter ended September 30, 2026, confirming that securities received for dematerialization were accepted or rejected by System Support Services, the company’s Registrar and Share Transfer Agent (RTA).

Dharti Proteins Limited, formerly Devika Proteins Limited, announced that it will close its trading window for directors, promoters, designated persons, and specified connected persons from October 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter and half-year ending September 30, 2026, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

Net Loss of Dharti Proteins reported to Rs 0.14 crore in the quarter ended June 2026 as against net loss of Rs 0.05 crore during the previous quarter ended June 2025. There were no Sales reported in the quarter ended June 2026 and during the previous quarter ended June 2025.Powered by Capital Market - Live News

Dharti Proteins will hold a meeting of the Board of Directors of the Company on 15 July 2026.

Net loss of Dharti Proteins reported to Rs 0.46 crore in the quarter ended March 2026 as against net profit of Rs 0.02 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 and during the previous quarter ended March 2025.For the full year,net loss reported to Rs 0.85 crore in the year ended March 2026 as against net loss of Rs 0.01 crore during the previous year ended March 2025. There were no Sales reported in the year ended March 2026 and during the previous year ended March 2025.Powered by Capital Market - Live News